GlassScriptPhysician profile
William A Strickling
NPI 1225005770
$2,302.72
in general payments reported to CMS, 2019-2025
17 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $52.62 · 2021: $250 · 2022: $308 · 2023: $428 · 2024: $248 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $486.26 | 2019-2025 | Dupixent |
| Abbvie INC. | $475.36 | 2019-2023 | Rinvoq, Skyrizi |
| Amgen INC. | $240.66 | 2019-2024 | Otezla |
| Journey Medical Corporation | $207.32 | 2019-2025 | |
| Pfizer INC. | $201.02 | 2019-2025 | |
| Incyte Corporation | $123.08 | 2025 | Opzelura |
| Dermavant Sciences, INC. | $119.05 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $117.56 | 2021-2022 | |
| Allergan, INC. | $97.33 | 2019 | |
| Genzyme Corporation | $76.71 | 2022 | |
| Ucb, INC. | $40.01 | 2021-2022 | |
| Leo Pharma INC. | $29.99 | 2019-2022 | |
| Janssen Biotech, INC. | $21.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.41 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $16.12 | 2020 | |
| Prugen, INC. Pharmaceuticals | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Strickling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.